Power Law company profile

Abcuro

Biotech & Life Sciences · Newton, United States · Founded 2015

Abcuro, Inc. is a biotechnology company focused on developing advanced immunotherapies to treat autoimmune diseases and cancer. The company operates in the biopharmaceutical market, specifically targeting dysfunctional immune pathways to create novel therapies. Abcuro takes a patient-centric approach, identifying and validating the role of these pathways in various diseases to discover new treatments. The company primarily serves patients suffering from autoimmune conditions and certain types of cancer. Abcuro's business model revolves around research and development, with revenue generated through partnerships, grants, and potential future sales of their proprietary therapies. The company is headquartered in Newton, MA, and is led by a team of experienced scientists and medical professionals. Key areas of focus include the role of KLRG1 T cells in diseases like Primary Biliary Cholangitis and Inclusion Body Myositis. Keywords: immunotherapies, T cells, autoimmunity, cancer, biotechnology, patient-centric, immune pathways, biopharmaceutical, KLRG1, research and development.

Valuation

$500M–1B

Latest valuation · 2025

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Total funding● Pre-IPO

$100–500M

Unlock exact value

Investors

14 investors on Abcuro's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 12 investors entered at this stage

Sanofi Ventures

RA Capital Management

Samsara BioCapital

Tekla Capital Management

Pontifax Funds

Redmile Group

Bain Capital Life Sciences

Eurofarma

New Leaf Ventures

BlackRock

Soleus Capital

Mass General Brigham Ventures

Series B+ 2 investors entered at this stage

NEA

Foresite Capital

Global footprint

Where Abcuro has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States94.7%

🇩🇰 Denmark2.6%

🇦🇺 Australia2.6%

3 countries shown

Talent graph

The shape of Abcuro's talent

Dealroom maps Abcuro's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

13 team members profilednamed & role-tagged by Dealroom

40 employeestotal headcount

4 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Abcuro's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Abcuro

An AI-synthesized read of the highest-engagement posts about Abcuro on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abcuro on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles